vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Atour Lifestyle Holdings Ltd (ATAT). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $789.6M, roughly 1.2× Atour Lifestyle Holdings Ltd). Atour Lifestyle Holdings Ltd runs the higher net margin — 17.6% vs 0.7%, a 16.9% gap on every dollar of revenue. On growth, Atour Lifestyle Holdings Ltd posted the faster year-over-year revenue change (252.5% vs 42.9%). Atour Lifestyle Holdings Ltd produced more free cash flow last quarter ($210.7M vs $-6.0M).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Atour Lifestyle Holdings Ltd is a leading China-based hospitality and lifestyle enterprise. It operates a wide portfolio of mid-to-premium hotel brands for business and leisure travelers, and offers complementary lifestyle retail products and experience services, catering primarily to middle-class consumers across domestic and selected overseas markets.
ASTH vs ATAT — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $789.6M |
| Net Profit | $6.6M | $139.1M |
| Gross Margin | — | — |
| Operating Margin | 1.9% | 22.5% |
| Net Margin | 0.7% | 17.6% |
| Revenue YoY | 42.9% | 252.5% |
| Net Profit YoY | 184.4% | 322.2% |
| EPS (diluted) | $0.12 | $0.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | — | ||
| Q3 25 | $956.0M | $789.6M | ||
| Q2 25 | $654.8M | — | ||
| Q1 25 | $620.4M | — | ||
| Q4 24 | $665.2M | — | ||
| Q3 24 | $478.7M | $224.0M | ||
| Q2 24 | $486.3M | — | ||
| Q1 24 | $404.4M | $203.4M |
| Q4 25 | $6.6M | — | ||
| Q3 25 | $373.0K | $139.1M | ||
| Q2 25 | $9.4M | — | ||
| Q1 25 | $6.7M | — | ||
| Q4 24 | $-7.8M | — | ||
| Q3 24 | $16.1M | $33.0M | ||
| Q2 24 | $19.2M | — | ||
| Q1 24 | $14.8M | $35.6M |
| Q4 25 | 1.9% | — | ||
| Q3 25 | 2.0% | 22.5% | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | 3.3% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 5.9% | 14.7% | ||
| Q2 24 | 6.2% | — | ||
| Q1 24 | 7.5% | 22.1% |
| Q4 25 | 0.7% | — | ||
| Q3 25 | 0.0% | 17.6% | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | 3.4% | 14.7% | ||
| Q2 24 | 3.9% | — | ||
| Q1 24 | 3.7% | 17.5% |
| Q4 25 | $0.12 | — | ||
| Q3 25 | $0.01 | $0.33 | ||
| Q2 25 | $0.19 | — | ||
| Q1 25 | $0.14 | — | ||
| Q4 24 | $-0.14 | — | ||
| Q3 24 | $0.33 | $0.08 | ||
| Q2 24 | $0.40 | — | ||
| Q1 24 | $0.31 | $0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $669.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.3M | $405.0M |
| Total Assets | $2.2B | $1.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | — | ||
| Q3 25 | $463.4M | $669.2M | ||
| Q2 25 | $342.1M | — | ||
| Q1 25 | $260.9M | — | ||
| Q4 24 | $290.8M | — | ||
| Q3 24 | $350.3M | $506.0M | ||
| Q2 24 | $327.7M | — | ||
| Q1 24 | $337.3M | $520.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $277.0K |
| Q4 25 | $779.3M | — | ||
| Q3 25 | $775.5M | $405.0M | ||
| Q2 25 | $765.5M | — | ||
| Q1 25 | $745.4M | — | ||
| Q4 24 | $712.7M | — | ||
| Q3 24 | $704.6M | $291.3M | ||
| Q2 24 | $678.9M | — | ||
| Q1 24 | $653.5M | $323.5M |
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | $1.1B | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.3B | $927.8M | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.2B | $936.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $216.6M |
| Free Cash FlowOCF − Capex | $-6.0M | $210.7M |
| FCF MarginFCF / Revenue | -0.6% | 26.7% |
| Capex IntensityCapex / Revenue | 0.3% | 0.8% |
| Cash ConversionOCF / Net Profit | -0.44× | 1.56× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $359.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | — | ||
| Q3 25 | $10.0M | $216.6M | ||
| Q2 25 | $90.9M | — | ||
| Q1 25 | $16.6M | — | ||
| Q4 24 | $-10.9M | — | ||
| Q3 24 | $34.0M | $84.8M | ||
| Q2 24 | $23.2M | — | ||
| Q1 24 | $6.0M | $19.8M |
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | $210.7M | ||
| Q2 25 | $89.5M | — | ||
| Q1 25 | $13.6M | — | ||
| Q4 24 | $-13.5M | — | ||
| Q3 24 | $31.7M | $83.3M | ||
| Q2 24 | $20.4M | — | ||
| Q1 24 | $5.6M | $18.1M |
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | 26.7% | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | -2.0% | — | ||
| Q3 24 | 6.6% | 37.2% | ||
| Q2 24 | 4.2% | — | ||
| Q1 24 | 1.4% | 8.9% |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | 0.8% | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.5% | 0.7% | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.1% | 0.9% |
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | 1.56× | ||
| Q2 25 | 9.65× | — | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | 2.57× | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 0.40× | 0.56× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
ATAT
Segment breakdown not available.
